Aerpio Pharmaceuticals, Inc.

ARPO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$18-$53$73-$14
Dep. & Amort.-$1$0$0-$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$3$2$10
Change in WC-$1$0$0$0
Other Non-Cash$1-$3-$87-$14
Operating Cash Flow-$15-$53-$12-$20
Investing Activities
PP&E Inv.$0-$0-$1$4
Net Acquisitions-$101$0$0$0
Inv. Purchases-$94-$32$0-$36
Inv. Sales/Matur.$2$3$15$63
Other Inv. Act.$101$0$101$0
Investing Cash Flow-$92-$29$115$31
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$100$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$1$95-$54
Financing Cash Flow$0-$1$95-$54
Forex Effect$0$0$0$0
Net Chg. in Cash-$107-$83$199-$1
Supplemental Information
Beg. Cash$145$228$29$30
End Cash$38$145$228$29
Free Cash Flow-$15-$53-$12-$16